Arnaud Prigent

Dr. Arnaud Prigent

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2021 in Respirology
Verified
Journal Article
Closed access
PDF file
APArnaud Prigent
Arnaud Prigent
CPClaude Pellen
Claude Pellen
JTJoëlle Texereau
Joëlle Texereau
Sébastien BaillySébastien Bailly
Sébastien Bailly
NCNicolas Coquerel
Nicolas Coquerel
JPJean-Louis Pepin
Jean-Louis Pepin

29 August 2023 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
JPJean-Louis Pepin
Jean-Louis Pepin
PLPauline Lemeille
Pauline Lemeille
HDHélène Denis
Hélène Denis
AJAnne Josseran
Anne Josseran
FLFlorent Lavergne
Florent Lavergne
APArnaud Prigent
Arnaud Prigent
Chronic obstructive pulmonary disease (COPD) is the most common indication for long-term domiciliary non-invasive ventilation (NIV) but there is uncertainty in data supporting current guidelines. This study described health trajectories before initiation of at-home NIV in people with COPD, and compared mortality outcomes between groups with different pre-NIV health trajectories. Data were from the French national health insurance reimbursement system database for individuals with COPD aged ≥40 years and ≥1 reimbursement for NIV between 1 January 2015 and 31 December 2019. Common health trajectories were determined using time sequence analysis through K-clustering (TAK analysis). Data from 54,545 individuals were analysed; the population was elderly (median age 70 years) with multiple comorbidities. Four clusters were generated. Cluster 1 (n = 35,975/54,545; 66%) had NIV initiated in ambulatory settings or after the first acute event/exacerbation. Cluster 2 (6653/54,545; 12%) started NIV after ≥2 severe exacerbations in the previous 6 months. Cluster 3 (11,375/54,545; 21%) started NIV after frequent severe COPD-related exacerbations in the previous year. Cluster 4 (652/54,545; 1%) started NIV after many long-lasting severe exacerbations. The four clusters differed in age, sex, comorbidities, pre-NIV investigations, and prescriber/location of NIV initiation. Mortality differed significantly between clusters: highest in Cluster 4 and lowest in Cluster 1. The significant heterogeneity in clinical initiation of NIV probably reflects the current lack of strong evidence and guideline recommendations. Knowledge about the characteristics and outcomes in different clusters should be used to address inequities and facilitate more consistent and personalised use domiciliary NIV in COPD. JLP and SB are supported by the 10.13039/501100001665 French National Research Agency in the framework of the “Investissements d’avenir” program (ANR-15-IDEX-02) and the “e-health and integrated care and trajectories medicine and MIAI artificial intelligence (ANR-19-P3IA-0003)” Chairs of excellence from the 10.13039/100019979 Grenoble Alpes University Foundation . This work was supported by 10.13039/100017647 ResMed .

22 September 2020 in Respirology Case Reports
Verified
Journal Article
Open access
PDF file
APArnaud Prigent
Arnaud Prigent
ASAnne‐Laure Serandour
Anne‐Laure Serandour
RLRégis Luraine
Régis Luraine
JPJean Sébastien Poineuf
Jean Sébastien Poineuf
CBChristian Bosseau
Christian Bosseau
JPJean‐Louis Pépin
Jean‐Louis Pépin
We report the case of a 71‐year‐old obese continuous positive airway pressure (CPAP)‐treated man who developed an acute cardiac failure (ACF) triggered by atrial fibrillation. CPAP data downloaded from the CPAP software (Rescan®) retrospectively demonstrated the progressive development of a high residual central apnoea–hypopnoea index (AHI) with Cheyne–Stokes respiration (CSR). The AHI decreased after cardioversion allowing normalization of cardiac rhythm and function. Raw data extracted from CPAP software showed a gradual decrease in the periodic breathing cycle length related to a simultaneous improvement in left ventricular ejection fraction (LVEF) after cardioversion. During this clinical period of respiratory instability in the presence of cardiac failure, CSR episodes were exacerbated by ventilation overshoots followed by micro‐arousals induced by leaks. This might explain the high night to night variability of CSR occurrence in susceptible patients with impaired cardiac function. Beyond attempts to improve cardiac function, leak reduction might represent an important target for CSR management.

1 September 2020 in Revue des Maladies Respiratoires
Verified
Journal Article
Closed access
APArnaud Prigent
Arnaud Prigent
TGT. Gentina
T. Gentina
SLS. Launois
S. Launois
JMJ.C. Meurice
J.C. Meurice
MDM. Pia D’oRtho
M. Pia D’oRtho
DJD. Jaffuel
D. Jaffuel

1 April 2025 in Thorax
Verified
Journal Article
Open access
PDF file
APArnaud Prigent
Arnaud Prigent
JTJoëlle B Texereau
Joëlle B Texereau
CSClaude Schmitz
Claude Schmitz
CRCécile Ropars
Cécile Ropars
JDJean-Marc Degreef
Jean-Marc Degreef
CMCapucine Morelot-Panzini
Capucine Morelot-Panzini
Rationale: Telemonitoring has shown benefits during the initiation of home non-invasive ventilation (NIV) but evidence is lacking regarding its use during follow-up. A French national telemonitoring programme incorporating remote support and therapeutic education is designed to improve patient pathways and reduce healthcare resource utilisation. This study investigated the impact of the telemonitoring programme versus usual follow-up on the effectiveness of home NIV.Methods: The prospective, multicentre, open-label eVENT trial enrolled adults recently started on home NIV. Participants were randomised to the telemonitoring or usual follow-up group. In the telemonitoring group, a CE-marked algorithm generated alerts based on teletransmitted ventilator data. Specialised nurses managed alerts and provided therapeutic education. The primary outcome was mean nocturnal transcutaneous carbon dioxide level (PtCO2) on NIV after 6 months.Results: 56 patients were randomised and 53 were analysed (telemonitoring: n=27, usual follow-up: n=26). At 6 months, mean PtCO2did not differ significantly between the telemonitoring and usual follow-up groups (42.1±6.1 vs 43.9±6.4 mm Hg; p=0.352) but mean room air partial arterial carbon dioxide pressure (PaCO2) was significantly lower in the telemonitoring versus usual follow-up group (41.7±6.8 vs 46.2±3.5 mm Hg; p=0.003). The proportion of participants without diurnal or nocturnal hypercapnia at 6 months was 82.6% with telemonitoring and 27.3% with usual follow-up (p<0.001). Compared with usual follow-up, the telemonitoring group had greater NIV use, more days with NIV usage ≥4 hour and less non-intentional leaks.Conclusions: In patients on home NIV, PtCO2was similar with telemonitoring and usual follow-up, but PaCO2levels and the quality of ventilatory support were significantly better with telemonitoring.Trial registration number: NCT04615078.

15 December 2017 in Journal of Clinical Sleep Medicine
Verified
Journal Article
Closed access
APArnaud Prigent
Arnaud Prigent
LGLeo Grassion
Leo Grassion
SGStephanie Guesdon
Stephanie Guesdon
JGJesus Gonzalez-Bermejo
Jesus Gonzalez-Bermejo
Continuous positive airway pressure (CPAP) is currently the reference treatment for obstructive sleep apnea (OSA). The use of a face mask, although sometimes necessary, is often associated with increased airway obstruction due to mandibular retrusion. We report a small group of patients in whom addition of a cervical collar to a face mask allowed correction of obstructive events.